Sign in

CIK 0001022079

  • Large accelerated filer

QUEST DIAGNOSTICS INC

Sign in to watch
Ticker
DGX
Exchange
NYSE
Industry
Services-Medical Laboratories
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
161387862
Phone
+1 973-520-2700
Business address
500 PLAZA DRIVE, SECAUCUS, NJ, 07094
Former names
CORNING CLINICAL LABORATORIES INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$19,794,069
in 6 filings, $19.8M under 10b5-1 plans

Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-03-07 PREVOZNIK MICHAEL E SVP & General Counsel Shares withheld for taxes −5,316 $130.09 $692K 45,452
2022-03-07 GUINAN MARK Executive Vice President & CFO Grant or award +20,780 $130.09 $2.7M 109,456
2022-03-07 GUINAN MARK Executive Vice President & CFO Shares withheld for taxes −10,475 $130.09 $1.4M 98,981
2022-03-07 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Grant or award +16,162 $130.09 $2.1M 56,338
2022-03-07 EGLINTON MANNER CARRIE SVP, Advanced Diagnostics Shares withheld for taxes −7,947 $130.09 $1.0M 48,391
2022-03-07 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Grant or award +13,392 $130.09 $1.7M 81,125
2022-03-07 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Shares withheld for taxes −6,360 $130.09 $827K 74,765
2022-03-07 Davis J. E. EVP-Gen. Diagnostics/CEO Elect Grant or award +19,856 $130.09 $2.6M 77,138
2022-03-07 Davis J. E. EVP-Gen. Diagnostics/CEO Elect Shares withheld for taxes −10,330 $130.09 $1.3M 66,808
2022-02-28 PREVOZNIK MICHAEL E SVP & General Counsel Sale −661 $130.00 $86K 39,224
2022-02-24 RUSCKOWSKI STEPHEN H Chairman, CEO and President Grant or award +22,510 297,219
2022-02-24 RUSCKOWSKI STEPHEN H Chairman, CEO and President Grant or award · Non-Qualifed Stock Option (right to buy) +109,317 109,317
2022-02-24 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Sale −2,750 $126.26 $347K 64,405
2022-02-24 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Grant or award +3,328 67,733
2022-02-24 Doherty Catherine T. SVP, Group Exec. Clin. Fran. Grant or award · Non-Qualifed Stock Option (right to buy) +16,155 16,155
2022-02-24 Davis J. E. EVP-Gen. Diagnostics/CEO Elect Grant or award +9,787 57,282
2022-02-24 Davis J. E. EVP-Gen. Diagnostics/CEO Elect Grant or award · Non-Qualifed Stock Option (right to buy) +47,529 47,529
2022-02-24 DEPPE MICHAEL J VP, Corp. Controller & CAO Grant or award +549 27,276
2022-02-24 DEPPE MICHAEL J VP, Corp. Controller & CAO Grant or award +3,132 30,408
2022-02-24 DEPPE MICHAEL J VP, Corp. Controller & CAO Grant or award · Non-Qualifed Stock Option (right to buy) +2,654 2,654

Page 32 of 42 · 826 trades